NCT02424942View on ClinicalTrials.gov

First-in-human Study With Ascending Single Intra-articular Doses of GZ389988 in Patients With Painful Osteoarthritis of the Knee

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Osteoarthritis

Interventions

DRUG

placebo

"Pharmaceutical form:solvent for parenteral use~Route of administration: intraarticular"

DRUG

GZ389988

"Pharmaceutical form:suspension for injection~Route of administration: intraarticular"

Trial Locations (1)

14050

Investigational Site Number 276001, Berlin

All Listed Sponsors

lead

Genzyme, a Sanofi Company

INDUSTRY

NCT02424942 - First-in-human Study With Ascending Single Intra-articular Doses of GZ389988 in Patients With Painful Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter